Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
biote Corp. stock logo
BTMD
biote
$1.15
-1.7%		$1.45
$1.06
▼
$3.26
$42.04M1.69139,074 shs45,559 shs
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$0.94
$0.98
$0.80
▼
$1.49
$12.03M0.174,543 shsN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$4.95
-6.8%		$8.76
$1.52
▼
$16.89
$38.56M1.712,313 shs10,070 shs
Precipio, Inc. stock logo
PRPO
Precipio
$23.12
-0.3%		$25.63
$16.40
▼
$33.63
$41.51M1.388,114 shs22,201 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
biote Corp. stock logo
BTMD
biote
+5.41%+0.86%-22.52%-49.79%-59.23%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%+0.32%-8.74%+13.25%-21.67%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-4.07%-15.31%-40.87%-45.82%-40.67%
Precipio, Inc. stock logo
PRPO
Precipio
-1.40%+2.02%-14.90%-2.56%+26.38%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
biote Corp. stock logo
BTMD
biote
$1.15
-1.7%		$1.45
$1.06
▼
$3.26
$42.04M1.69139,074 shs45,559 shs
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$0.94
$0.98
$0.80
▼
$1.49
$12.03M0.174,543 shsN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$4.95
-6.8%		$8.76
$1.52
▼
$16.89
$38.56M1.712,313 shs10,070 shs
Precipio, Inc. stock logo
PRPO
Precipio
$23.12
-0.3%		$25.63
$16.40
▼
$33.63
$41.51M1.388,114 shs22,201 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
biote Corp. stock logo
BTMD
biote
+5.41%+0.86%-22.52%-49.79%-59.23%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%+0.32%-8.74%+13.25%-21.67%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-4.07%-15.31%-40.87%-45.82%-40.67%
Precipio, Inc. stock logo
PRPO
Precipio
-1.40%+2.02%-14.90%-2.56%+26.38%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
biote Corp. stock logo
BTMD
biote
2.50
Moderate Buy$2.50117.39% Upside
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00
N/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
2.00
Hold$17.00243.43% Upside
Precipio, Inc. stock logo
PRPO
Precipio
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PFHO, PRPO, PIII, and BTMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/13/2026
biote Corp. stock logo
BTMD
biote
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
8/11/2026
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$23.00
8/10/2026
biote Corp. stock logo
BTMD
biote
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$2.00 ➝ $1.50
8/7/2026
biote Corp. stock logo
BTMD
biote
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$2.50 ➝ $2.00
7/17/2026
Precipio, Inc. stock logo
PRPO
Precipio
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
biote Corp. stock logo
BTMD
biote
$183.53M0.23$0.57 per share2.02($1.40) per share-0.82
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$6.72M1.79$0.11 per share8.52$1.02 per share0.92
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
$1.50B0.02N/AN/A($21.55) per share-0.23
Precipio, Inc. stock logo
PRPO
Precipio
$24.05M1.72$0.79 per share29.19$8.31 per share2.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
biote Corp. stock logo
BTMD
biote
$27.05M$0.1110.466.76N/A3.19%-22.33%12.10%11/4/2026 (Estimated)
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$1.39M$0.0910.45N/AN/A15.19%7.42%7.17%N/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$147.95M-$33.00N/AN/AN/A-6.55%N/A-16.40%11/12/2026 (Estimated)
Precipio, Inc. stock logo
PRPO
Precipio
-$360K-$0.64N/AN/AN/A-4.47%-8.49%-5.75%11/16/2026 (Estimated)

Latest PFHO, PRPO, PIII, and BTMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
biote Corp. stock logo
BTMD
biote
-$0.05N/AN/AN/A$44.01 millionN/A
8/14/2026Q2 2026
Precipio, Inc. stock logo
PRPO
Precipio
-$2.00-$0.12+$1.88-$0.12$1.68 million$7.02 million
8/10/2026Q2 2026
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
-$1.89-$0.63+$1.26-$0.63$377.80 million$386.38 million
8/5/2026Q2 2026
biote Corp. stock logo
BTMD
biote
$0.0267-$0.23-$0.2567-$0.23$46.12 million$44.23 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
biote Corp. stock logo
BTMD
biote
N/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
N/AN/AN/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
biote Corp. stock logo
BTMD
biote
N/A
1.43
0.82
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
27.21
27.21
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
N/A
0.46
0.46
Precipio, Inc. stock logo
PRPO
Precipio
0.06
1.77
1.56

Institutional Ownership

CompanyInstitutional Ownership
biote Corp. stock logo
BTMD
biote
21.68%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
7.75%
Precipio, Inc. stock logo
PRPO
Precipio
10.45%

Insider Ownership

CompanyInsider Ownership
biote Corp. stock logo
BTMD
biote
32.40%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
61.60%
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
10.86%
Precipio, Inc. stock logo
PRPO
Precipio
16.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
biote Corp. stock logo
BTMD
biote
22335.93 million24.29 millionNot Optionable
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
3012.80 million4.92 millionNot Optionable
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
3207.26 million6.47 millionNot Optionable
Precipio, Inc. stock logo
PRPO
Precipio
711.79 million1.49 millionNo Data

Recent News About These Companies

Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average – What’s Next?
October 7 at 4:00 AM  |  defenseworld.netD
Head to Head Review: The Pennant Group (NASDAQ:PNTG) & Precipio (NASDAQ:PRPO)
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31085811
Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average - What's Next?
September 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31062266
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
September 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2993959/prpo-vs-flgt-which-cancer-diagnostics-stock-has-more-upside-now?cid=cs-stocknewsapi-ft-microcap_article|investment_ideas-2993959
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
August 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2979242/prpo-vs-bdsx-which-cancer-diagnostics-stock-is-the-better-buy-now?cid=cs-stocknewsapi-ft-microcap_article|investment_ideas-2979242
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong
August 21, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2978453/precipio-stock-gains-post-q2-earnings-revenue-momentum-strong?cid=cs-stocknewsapi-ft-microcap_article|earnings-2978453
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
August 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937463-precipio-inc-prpo-q2-2026-earnings-call-transcript
Precipio Announces Q2-2026 Financial Results
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345592/0/en/precipio-announces-q2-2026-financial-results.html
Precipio Schedules Q2 2026 Shareholder Update Call
July 31, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/precipio-schedules-q2-2026-shareholder-update-call?utm_source=marketbeat.com&utm_medium=referral
Precipio Announces Q2-2026 Shareholder Update Call
July 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/31/3337039/0/en/precipio-announces-q2-2026-shareholder-update-call.html
Precipio Earnings Estimates, EPS & Revenue | NASDAQ:PRPO
July 21, 2026  |  benzinga.comhttps://www.benzinga.com/quote/PRPO/earnings
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
July 16, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2954904/prpo-vs-neo-which-cancer-diagnostics-stock-is-the-better-buy?cid=cs-stocknewsapi-ft-microcap_article|investment_ideas-2954904
Precipio Inc.
June 28, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/prpo/financials
Top analyst reports for Caterpillar, Palo Alto & Toyota
June 26, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/top-analyst-reports-for-caterpillar-palo-alto-toyota/ar-AA26E6uR
Precipio Shareholders Back Board Nominees and Auditor
June 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/precipio-shareholders-back-board-nominees-and-auditor?utm_source=marketbeat.com&utm_medium=referral
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
June 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/12/3311248/0/en/precipio-is-requesting-shareholders-brokers-vote-today-to-avoid-costly-adjournment-and-rescheduling-of-annual-shareholders-meeting.html
Precipio to Present at the Planet MicroCap Las Vegas
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/11/3310818/0/en/precipio-to-present-at-the-planet-microcap-las-vegas.html
Precipio (PRPO) Q1 2026 Earnings Call Transcript
June 2, 2026  |  fool.comhttps://www.fool.com/earnings/call-transcripts/2026/06/02/precipio-prpo-q1-2026-earnings-call-transcript/
Precipio (PRPO) Q4 2025 Earnings Transcript
June 2, 2026  |  aol.comA
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
May 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2925534/precipio-stock-slips-post-q1-earnings-despite-revenue-growth?cid=cs-stocknewsapi-ft-microcap_article|earnings-2925534

New MarketBeat Followers Over Time

Media Sentiment Over Time

biote stock logo

biote NASDAQ:BTMD

$1.15 -0.02 (-1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.87%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Pacific Health Care Organization stock logo

Pacific Health Care Organization OTCMKTS:PFHO

$0.94 0.00 (0.00%)
As of 10/8/2026

Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.

P3 Health Partners stock logo

P3 Health Partners NASDAQ:PIII

$4.95 -0.36 (-6.78%)
Closing price 04:00 PM Eastern
Extended Trading
$4.94 -0.01 (-0.20%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Precipio stock logo

Precipio NASDAQ:PRPO

$23.12 -0.07 (-0.30%)
Closing price 04:00 PM Eastern
Extended Trading
$23.06 -0.06 (-0.26%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas